TLR3 and breast cancer: Further, cell surface expression of TLR3 has been reported in a variety of cells such as pulmonary cells, hepatocytes, breast cancer, prostate cancer, and epithelial adenocarcinoma (4–6) indicating that its signaling occurs through the plasma membrane.